Evaluation of antidepressant properties of the p38 MAP kinase inhibitor losmapimod (GW856553) in Major Depressive Disorder: Results from two randomised, placebo-controlled, double-blind, multicentre studies using a Bayesian approach.
about
Evaluation of antidepressant properties of the p38 MAP kinase inhibitor losmapimod (GW856553) in Major Depressive Disorder: Results from two randomised, placebo-controlled, double-blind, multicentre studies using a Bayesian approach.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Evaluation of antidepressant p ...... ies using a Bayesian approach.
@en
Evaluation of antidepressant p ...... ies using a Bayesian approach.
@nl
type
label
Evaluation of antidepressant p ...... ies using a Bayesian approach.
@en
Evaluation of antidepressant p ...... ies using a Bayesian approach.
@nl
prefLabel
Evaluation of antidepressant p ...... ies using a Bayesian approach.
@en
Evaluation of antidepressant p ...... ies using a Bayesian approach.
@nl
P2093
P2860
P356
P1476
Evaluation of antidepressant p ...... ies using a Bayesian approach.
@en
P2093
Amir Inamdar
Clare Makumi
Emiliangelo Ratti
Emilio Merlo-Pich
Erik Steinberg
Jon Robertson
Michelle Gee
Prafull Mistry
Robert Alexander
Stefano Zamuner
P2860
P304
P356
10.1177/0269881114529377
P407
P577
2014-04-02T00:00:00Z